Apple Loses Blood Oxygen Patent Case
A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen-monitoring technology.
Reuters reports the jury found that the Apple Watch’s workout mode and heart rate notification features violated Masimo’s patent.
“Over the past six years (Masimo has) sued Apple in multiple courts and asserted over 25 patents, the majority of which have been found to be invalid,” an Apple spokesperson told Reuters. “The single patent in this case expired in 2022, and is specific to historic patient monitoring technology from decades ago.”
[…]
Apple’s workaround did not sit well with Masimo, which filed another lawsuit in an attempt to overturn the U.S. Customs decision and once again prevent Apple from selling Apple Watch models with the blood oxygen feature in the U.S., but there has yet to be a ruling in that lawsuit.
I’m not sure which patent was at issue here. I thought it was this one, but Google says that doesn’t expire until 2028.
Previously:
- The Return of Blood Oxygen for Apple Watch
- Apple Watch Sales Paused Over Masimo Patent
- Masimo v. Apple
